Arundhati Guru
Individuals who experienced both acute myocardial infarction and hyperglycaemic myocardial infarction upon admission to the hospital had a worse prognosis than those who did not. The ability of sodium-glucose co-transporter-2 myocardial infarction inhibitors to treat acute hyperglycaemic myocardial infarction and the underlying processes remains unknown. When non-diabetic myocardial infarction caused by a glucose injection cooccurred with acute hyperglycaemic myocardial infarction in WT myocardial infarction. The survival rate was lower than in the control group. After using empagliflozin, a notable improvement in LV function and survival was seen. Also, when a myocardial infarction was coupled with an acute hyperglycaemic myocardial infarction, empagliflozin decreased fibrosis and autophagy of border cardiac tissue.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 